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Smoke free hospitals
An achievable objective bringing benefits for patients and staff
The Royal Victoria Hospital in Belfast has oftenbeen in the media spotlight, attracting praise forthe way it responded to three decades of
intercommunal violence in Northern Ireland. Some
recent news coverage was not, however, quite so positive.
The hospital is nearing completion of a major new
building development, and the BBC revealed how the
hospital’s management had decided to establish seven
smoking rooms for patients and staff in it at a cost of
£500 000 ($787 000; €723 000).1 The decision immedi-
ately provoked condemnation from many sources. Dr
Joe Hendron, a member of the Northern Ireland assem-
bly and also a local general practitioner, argued that the
move sent out the wrong signal at a time when health
services should be encouraging people to stop smoking
and Andrew Dougal, of the Northern Ireland Chest,
Heart, and Stroke Association condemned the “abject
failure” of the hospital to persuade people to quit smok-
ing. Hospital managers have, however, stuck to their
decision, arguing that they are simply accepting reality
as staff and patients “don’t leave their cigarettes and
matches at home when they come here.”
The hospital’s decision contrasts with the growing
frequency of total bans on smoking in health facilities.
Since the beginning of 1994 the United States joint
commission on accreditation of healthcare organisa-
tions has required that accredited hospitals be smoke
free, and a survey conducted soon afterwards showed
that over 96% of hospitals had complied with the stand-
ard, with over 40% going further than required by it.2
Elsewhere,many individual hospitals have acted on their
own initiative or in association with groups such as the
international network towards smoke free hospitals or
the European network for smoke free hospitals.
Two main considerations are involved. One is the
importance of sending out a consistent message. Many
of the elements of a comprehensive tobacco policy are at
last falling into place in the United Kingdom, with a ban
on tobacco advertising, larger warnings on cigarette
packs, and greater support for people who wish to quit.
One key area where action is still needed is a ban on
smoking in public places, as recently urged by the British
Medical Association.3 The value of hospitals making a
clear statement on public smoking can be seen from a
recent systematic review showing that total workplace
bans would have an effect equivalent to an almost dou-
bling of the price of cigarettes in the United Kingdom.4
The second consideration is protection of other
patients and staff from exposure to second hand smoke,
the dangers of which have long been obscured by the
tobacco industry. Other factors include a reduction in
the risk of fires and in cleaning costs.
Some will argue that bans on smoking in hospitals
will not work because of opposition by staff or patients.
Many health professionals have experienced abuse
when challenging addicted smokers who ignore no
smoking signs, and preventing smoking by patients
experiencing nicotine withdrawal symptoms is espe-
cially difficult. However, a Cochrane review found that
carefully planned and resourced multicomponent
strategies are effective in reducing smoking in public
places.5 A set of case studies undertaken by the Health
Development Agency confirms that smoking bans can
work in NHS hospitals if designed and implemented
appropriately.6
Hospitals seeking practical guidance on implement-
ing a comprehensive tobacco control policy can find
guidance in another document from the Health
Development Agency,7 or, in most European languages,
from the European network for smoke free hospitals. In
brief, one should start with a review of existing policies,
focusing on implementation and gaps in adherence, fol-
lowed by preparation for and then implementation of
appropriate changes, establishment of monitoring
systems, and implementation of a continuing process of
audit. Critical success factors include building consensus
among all staff, whose support is often underestimated
by management, and integrating the smoking ban
within other hospital policies.
But should hospitals go further and actively help
patients to quit either before coming into hospital or
during and after their stay? Smoking cessation is a key
priority in the English national service framework for
coronary heart disease and in similar documents in
other parts of the United Kingdom, and the evidence
brought together by the Health Development Agency
shows that it can make an important contribution to
the effectiveness of smoking bans. The potential
benefits are considerable. Continuing to smoke is an
important risk factor for postoperative chest infection,8
wound breakdown,9 admission to an intensive care
unit,8 and in-hospital mortality.8 Smoking cessation
after surgery is an important independent predictor of
survival and risk of reoperation among patients under-
going coronary bypass surgery.10
Intervention is effective both before and during hos-
pitalisation. In a randomised controlled trial of smoking
intervention using counselling and nicotine replace-
ment among patients six to eight weeks before surgery,
nearly 90% of those in the intervention group either
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ceased or reduced smoking before surgery compared
with less than 10% of those in the control group.11 The
intervention group was much less likely to experience
postoperative complications, especially wound healing
and cardiovascular complications, and to need second-
ary surgery. A Cochrane review found that intensive
behavioural interventions with patients admitted to hos-
pital were associated with higher quit rates when linked
to follow up contact for at least a month.12
Given this evidence, it is arguable that resources
expended on smoking rooms might be better used to
fund a concerted effort to implement a smoking ban
and to expand smoking cessation activities. Hopefully
other hospitals facing a similar situation will act
differently in the future.
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Comparing cannabis with tobacco
Smoking cannabis, like smoking tobacco, can be a major public health hazard
Britain now has 13 million tobacco smokers. Thisnumber has been steadily decreasing due topublic awareness of the harm caused by
tobacco smoking. At the same time the number of can-
nabis smokers is increasing. Between 1999 and 2001,
the number of 14-15 year olds who had tried cannabis
rose from 19% to 29% in boys and 18% to 25% in girls,
and a Home Office document estimates that 3.2
million people in Britain smoke cannabis.1 2 However,
the harmful effects of smoking cannabis are widely
known and have recently been highlighted.3 4 Although
the active ingredients of the cannabis plant differ from
those of the tobacco plant, each produces about 4000
chemicals when smoked and these are largely identical.
Although cannabis cigarettes are smoked less fre-
quently than nicotine cigarettes, their mode of inhala-
tion is very different. Compared with smoking tobacco,
smoking cannabis entails a two thirds larger puff
volume, a one third larger inhaled volume, a fourfold
longer time holding the breath, and a fivefold increase
in concentrations of carboxyhaemoglobin.5 The prod-
ucts of combustion from cannabis are thus retained to
a much higher degree. How is this likely to translate
into adverse effects on health?
We already know that regular use of cannabis is
associated with an increased incidence of mental
illnesses, most notably schizophrenia and depression,4
but it is also worth examining its potential to cause other
illnesses, especially those of the heart and respiratory
system.
At present, there is an understandable dearth of
epidemiological evidence of cardiopulmonary harm
from cannabis, because its use is a relatively new
phenomenon and its potency is changing. The amount
of the main active constituent, tetrahydrocannabinol
(THC), in cannabis has increased from about 0.5% 20
years ago to nearer 5% at present in Britain, whereas
“Nederweed” (the variety smoked in the Netherlands)
has an average of 10-11% tetrahydrocannabinol. At the
same time little study has been undertaken of any con-
comitant change in the content of tar. Case-control
studies are difficult to perform since cannabis
cigarettes do not come in standard sizes, which makes
dose-response relations difficult to establish. Further-
more, most users of cannabis also smoke tobacco,
which makes it difficult to dissect out individual risks.
As with tobacco, there will be a latent period between
the onset of smoking and the development of lung
damage, cardiovascular disease, or malignant change.
Tobacco smoking is responsible for 120 000 excess
deaths each year in Britain, 46 000 from cancers,
34 000 from chronic respiratory disorders, and 40 000
from diseases of the heart and circulation. However,
there are indications that smoked cannabis may cause
similar effects to smoking tobacco, with many of them
appearing at a younger age. Smoking cannabis causes
chronic bronchitis, emphysema, and other lung
disorders, which were recently summarised in a review
released by the British Lung Foundation.3 A striking
feature of cannabis smoking is that it is associated with
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